Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial

Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial

Bibliographic Details
Published in:Nature Cancer 4(2023)1, S. 96-107
Main Authors: Denkinger, Claudia M. (Author), Janssen, Maike (Author), Pohle, Thorsten (Author), Ruhe, Matthias (Author)
Format: Article
Language:English
Published: 2023
Subjects:
Publikation <Klinikum Herford>
Medizinische Klinik I <Klinik, Klinikum Herford>
Klinikum Herford
Zeitschriftenartikel
Online Access:https://doi.org/10.1038/s43018-022-00503-w
Related Items:In: Nature Cancer
Description
Item Description:Exemplar/Standort: Open Access
DOI:10.1038/s43018-022-00503-w
Classmark:Open Access

Similar Items